Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

13/02/2018 06:30

Feb 13 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             13.18               12.84            17.70     
                 (+2.7 pct)          (-2.2 pct)       (+3.8 pct)   
  Operating        751 mln             547 mln          751 mln    
                 (+37.4 pct)         (-22.6 pct)      (-2.6 pct)   
  Recurring        774 mln             574 mln          778 mln    
                 (+34.8 pct)         (-20.6 pct)      (-3.1 pct)   
  Net              515 mln             373 mln          522 mln    
                 (+37.9 pct)         (-17.7 pct)      (+1.8 pct)   
  EPS            148.17 yen          107.47 yen       150.28 yen   
  Ann Div                             10.00 yen        10.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             10.00 yen        10.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))